发布求助
文献互助 智能选刊 最新文献

Annals of Oncology最新文献

筛选
英文 中文
29P Considering intra-patient response variability in clinical trials: Implications for treatment efficacy and survival
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.038
{"title":"29P Considering intra-patient response variability in clinical trials: Implications for treatment efficacy and survival","authors":"","doi":"10.1016/j.annonc.2024.08.038","DOIUrl":"10.1016/j.annonc.2024.08.038","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015576/pdfft?md5=41e22fecbac820d5cfd5e1d018fe18d8&pid=1-s2.0-S0923753424015576-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
15P TIGIT+ CD8+ T cells limit the efficacy of PD-L1 blockade plus chemoradiotherapy in MSS locally advanced rectal cancer via NECTIN2-TIGIT interplay
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.024
{"title":"15P TIGIT+ CD8+ T cells limit the efficacy of PD-L1 blockade plus chemoradiotherapy in MSS locally advanced rectal cancer via NECTIN2-TIGIT interplay","authors":"","doi":"10.1016/j.annonc.2024.08.024","DOIUrl":"10.1016/j.annonc.2024.08.024","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015436/pdfft?md5=a9c54f8f0ae74c3774f659f7ab88b2b4&pid=1-s2.0-S0923753424015436-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
17P Breaking chemotherapy resistance in gastric adenocarcinoma: Immunogenic cell death induction by carbonic anhydrase IX targeting
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.026
{"title":"17P Breaking chemotherapy resistance in gastric adenocarcinoma: Immunogenic cell death induction by carbonic anhydrase IX targeting","authors":"","doi":"10.1016/j.annonc.2024.08.026","DOIUrl":"10.1016/j.annonc.2024.08.026","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092375342401545X/pdfft?md5=a112353b04146452d5c46a76879e6d45&pid=1-s2.0-S092375342401545X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2P Single-cell profiling and integrative TCR analysis reveals tumor-mutation associated phenotypes and immune repertoire in lung adenocarcinoma
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.012
{"title":"2P Single-cell profiling and integrative TCR analysis reveals tumor-mutation associated phenotypes and immune repertoire in lung adenocarcinoma","authors":"","doi":"10.1016/j.annonc.2024.08.012","DOIUrl":"10.1016/j.annonc.2024.08.012","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092375342401531X/pdfft?md5=1f4c07ad4822a1b4140bf3de4f4c3afd&pid=1-s2.0-S092375342401531X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
93P UriMee: A novel non-invasive test for diagnosis of urothelial carcinoma by detection of methylation markers in urinary sediment DNA
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.101
{"title":"93P UriMee: A novel non-invasive test for diagnosis of urothelial carcinoma by detection of methylation markers in urinary sediment DNA","authors":"","doi":"10.1016/j.annonc.2024.08.101","DOIUrl":"10.1016/j.annonc.2024.08.101","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092375342401620X/pdfft?md5=69c97752d9a920eecd0149d17e6f936c&pid=1-s2.0-S092375342401620X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4P CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.014
{"title":"4P CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer","authors":"","doi":"10.1016/j.annonc.2024.08.014","DOIUrl":"10.1016/j.annonc.2024.08.014","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015333/pdfft?md5=267c99e7e15c307d31b8a274ebbf1626&pid=1-s2.0-S0923753424015333-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
28P Targeting YAP1 as a biomarker of resistance and therapeutic strategy in melanoma immunotherapy
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.037
{"title":"28P Targeting YAP1 as a biomarker of resistance and therapeutic strategy in melanoma immunotherapy","authors":"","doi":"10.1016/j.annonc.2024.08.037","DOIUrl":"10.1016/j.annonc.2024.08.037","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015564/pdfft?md5=745d7a979d7af3ab9efd2b4da7888086&pid=1-s2.0-S0923753424015564-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
16P PTEN deficiency leads to colorectal cancer immune evasion via atypical Keap1/Nrf2 pathway
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.025
{"title":"16P PTEN deficiency leads to colorectal cancer immune evasion via atypical Keap1/Nrf2 pathway","authors":"","doi":"10.1016/j.annonc.2024.08.025","DOIUrl":"10.1016/j.annonc.2024.08.025","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015448/pdfft?md5=788575bc92375292a81684e418b2acde&pid=1-s2.0-S0923753424015448-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142243362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
47P First-line pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) in the China subpopulation from the phase III KEYNOTE-966 study
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/j.annonc.2024.08.056
{"title":"47P First-line pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) in the China subpopulation from the phase III KEYNOTE-966 study","authors":"","doi":"10.1016/j.annonc.2024.08.056","DOIUrl":"10.1016/j.annonc.2024.08.056","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424015758/pdfft?md5=73714fad021b261a56aa778d2277258b&pid=1-s2.0-S0923753424015758-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regular
IF 56.7 1区 医学
Annals of Oncology Pub Date : 2024-09-01 DOI: 10.1016/S0923-7534(24)03804-3
{"title":"Regular","authors":"","doi":"10.1016/S0923-7534(24)03804-3","DOIUrl":"10.1016/S0923-7534(24)03804-3","url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":null,"pages":null},"PeriodicalIF":56.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0923753424038043/pdfft?md5=67ae0e6954b068a5a4e0ed74408b94e8&pid=1-s2.0-S0923753424038043-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信